Moncef Slaoui resigned as a board member of Intellia Therapeutics Inc. due to a conflict of interest, effective Aug. 7.
Slaoui was added to the board in July. His decision to resign did not result from any disagreement with the company on any matter relating to its operations, policies or practices.